The Valley Desk

NCT02621892 · Interventional trial

A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C

Overall registry status Completed

Phase 3

Conditions Constipation Predominant Irritable Bowel Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov